Check out the latest news from Cinclus Pharma
Cinclus Pharma participates at Redeye Investor Forum in Gothenburg October 10th. Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of linaprazan glurate.
Read more
Cinclus Pharma's CEO Christer Ahlberg was interviewed by Okee Williams at Redeye AB on September 23, about the company and the development of the drug candidate linaprazan glurate.
Read more
Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the Redeye Investor Forum Online on September 19th, 2024.
Read more